Shandra Eisenga Human Cell and Tissue Product Safety Act
Passed first chamber: it can still change before the session ends.
- Stage
- Passed first chamber
- Started in
- House
- Sponsors
- 2
- Latest action
- Jun 24, 2025
What it does
Shandra Eisenga Human Cell and Tissue Product Safety Act This bill establishes civil penalties for violations of regulations governing the donation and handling of human cell and tissue products. It also requires the Food and Drug Administration (FDA) to report on the regulation of these products and to provide related information to stakeholders. ( Human cell and tissue products are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.) Specifically, the bill establishes civil penalties for violations of the FDA’s regulations on donor eligibility and current good tissue practice for manufacturing and distributing human cell and tissue…
Official summary · Introduced in House · Feb 6, 2025
Titles and provisions can change as the bill moves.
Where it stands
Introduced (Done)
Committee (Done)
Floor (Current step)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.